Omkar Pharmachem share price
BSE: 532167Chemicals & PetrochemicalsSmall Cap
Omkar Pharmachem Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 1997
Last close ₹6.57down ₹0.33 (4.78%)
Share price at the BSE close on 27 Oct 2026. Previous close ₹6.90.
27 Oct: open ₹6.57, high ₹6.57, low ₹6.57
52-week range of traded prices to 27 Oct 2026
₹6.57Low, 27 Oct 2026₹29.74High, 15 Dec 2025
- Under BSE's graded surveillance, stage II, on the list for 27 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6.63 Cr3,900th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 77.77
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.18
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 0.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 101
Results
Standalone; ₹ crore.Omkar Pharmachem quarterly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- −22.2%
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- −52.3%
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹0.09 Cr0.00%
- Net profitNet profit. Under it, net profit in the quarter before. A change in per cent is not worked out where either period is a loss or nothing. Net profit in the glossary
- −₹0.01 CrQuarter to Mar 2026: ₹0.02 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- −11.1%
Revenue by quarter
Peak revenue ₹0.14 Cr, quarter to Sep 2024; lowest ₹0.09 Cr, quarter to Mar 2026
Net profit by quarter, a loss in red
- Net profit
- Loss
A loss in the quarter to Jun 2026, −₹0.01 CrA loss in 2 of the 8 quarters shown
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.11 | 0.09 | 0.09 |
| Net profit | 0.09 | 0.08 | −0.02 | 0.03 | 0.05 | 0.03 | 0.02 | −0.01 |
| Net margin | 65.6% | 62.9% | −15.9% | 19.7% | 37.6% | 28.1% | 16.7% | −11.1% |
Standalone. The last eight quarters. The latest is shaded.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹0.47 Crdown 13.89%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹0.12 Crdown 39.37%
- Net margin
- 26.2%
Revenue by year
Peak revenue ₹0.54 Cr, year to Mar 2022; lowest ₹0.00 Cr, year to Mar 2019
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 3 of the 10 years shown
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.01 | – | 0.00 | 0.05 | 0.27 | 0.54 | 0.54 | 0.54 | 0.54 | 0.47 |
| Net profit | 0.22 | −0.26 | −0.42 | −0.26 | 0.22 | 0.18 | 0.20 | 0.19 | 0.20 | 0.12 |
| Net margin | 3,683.3% | – | – | −576.9% | 82.0% | 33.9% | 36.6% | 35.0% | 37.2% | 26.2% |
Standalone. Years to March. The latest is shaded.
Business segments
In the year to Mar 2026 the company reports one business segment, Business Support Services, which carries all its revenue.
Omkar Pharmachem competitors and peers
Commodity Chemicals, 74 listed companies, priced on 28 Oct 2026. The table lists the 8 companies closest to Omkar Pharmachem in market cap. Omkar Pharmachem's own figures are from its last trade, on 27 Oct 2026. 2 companies in the table last traded before then: their rows are priced on their last trade.Chemical companies
Where the company sits among the companies nearest its size
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Emmessar Biotech & NutritionEMMESSA | 11 | 28.68 | 1.40 | −46.0% | −0.6% | 5.0% | −18.8% | 0.00% |
 Link Pharma ChemLINKPH | 11 | – | 0.84 | +16.3% | – | −0.1% | 1.2% | 0.00% |
 Sree chem ResinsSRECR | 10 | 233.01 | 0.71 | −15.5% | – | 0.3% | −1.1% | 0.00% |
 Kobo BiotechKOBO | 9 | – | – | – | – | – | – | 0.00% |
 Kuwer IndustriesKUWERIN | 9 | – | 0.46 | +34.8% | – | – | −6.2% | 0.00% |
 Lime ChemicalsLIMECHM | 8 | – | 4.71 | +35.5% | – | – | −3.0% | 0.00% |
 Bhagwati OxygenBHAGWOX | 8 | 2.71 | 1.11 | −34.4% | – | 53.0% | −17.2% | 0.00% |
 Padmanabh IndustriesPADMAIND | 5 | 19.53 | 27.70 | +643.7% | +282.4% | 141.9% | 32.8% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Omkar Pharmachem announcements
Oct 2026
Sep 2026
2 Sep · Meeting
Aug 2026
31 Aug · Board meeting
Omkar Pharmachem share price by year
Each calendar year to 2025.Omkar Pharmachem share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 29.74 | −0.9% | 30.00 | 25.50 |
| 2024 | 30.00 | +37.7% | 30.00 | 21.50 |
| 2023 | 21.78 | −8.3% | 25.00 | 19.40 |
| 2022 | 23.75 | +4.9% | 23.80 | 19.35 |
| 2021 | 22.65 | +19.8% | 22.70 | 18.30 |
| 2020 | 18.90 | +17.4% | 19.15 | 15.90 |
| 2019 | 16.10 | +25.8% | 16.10 | 12.80 |
| 2018 | 12.80 | +38.2% | 12.80 | 9.21 |
| 2017 | 9.26 | +52.6% | 9.26 | 6.37 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2024 is from its first session, 13 Feb 2024. 2021 is from its first session, 9 Feb 2021. 2020 is from its first session, 24 Feb 2020. 2018 is from its first session, 7 Mar 2018. 2017 is from its first session, 17 Feb 2017. The change in 2017 is on the close at the end of 2014, the last year before it with a trade. The close is the year's last trade for 2025 (15 Dec 2025), 2023 (1 Dec 2023), 2021 (13 Dec 2021), 2018 (10 Aug 2018) and 2017 (22 Nov 2017).
Recent sessions
The 9 trading days to 26 Oct 2026, as traded on BSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 26 Oct 2026 | 6.90 | 6.90 | 6.90 | 6.90 | 6.90 | 1 |
| 23 Oct 2026 | 7.23 | 7.23 | 7.23 | 7.23 | 7.23 | 100 |
| 22 Oct 2026 | 7.59 | 7.59 | 7.59 | 7.59 | 7.59 | 3 |
| 21 Oct 2026 | 7.91 | 7.91 | 7.60 | 7.60 | – | 52 |
| 19 Oct 2026 | 7.92 | 7.92 | 7.91 | 7.91 | 7.92 | 200 |
| 16 Oct 2026 | 8.32 | 8.32 | 8.32 | 8.32 | 8.32 | 50 |
| 15 Oct 2026 | 8.75 | 9.00 | 8.75 | 8.75 | 8.75 | 107 |
| 8 Oct 2026 | 9.21 | 9.21 | 9.21 | 9.21 | 9.21 | 100 |
| 7 Oct 2026 | 9.69 | 9.69 | 9.69 | 9.69 | 9.69 | 25 |
Prices in ₹ per share as traded, not adjusted.
Company details
- BSE code
- 532167
- ISIN
- INE501C01015
- Industry
- Chemicals & Petrochemicals
- Website
- www.omkarpharmachem.co.in
- CIN
- L93000GJ1995PLC025276
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1995
- Registered office
- 310, Wall Street - 1, Near Gujarat College Cross Road, Ellisbridge, Ahmedabad 380006
- Share registrar
- Alankit Assignments Ltd
- Keeps the register of shareholders and handles transfers and dividend payments